1) Researchers often pick a general prior for vitamin D based on all vitamin D trials. There are many failed vitamin D trials for things like cancer, diabetes, or all cause mortality.
This doesn't make sense to me because we should pick out prior based on similar diseases. Covid is a respiratory virus and trials of vitamin D in the respiratory context have shown a modest benefit.
2) Inconsistent evidentiary standards. Lots of researchers, including Dr. Bogoch, have placed great weight on anecdotal, ecological, or mechanistic evidence to argue that cloth masks are clearly effective.
The evidence for vitamin D isn't watertight by any means, but it's a heck of a lot stronger than the evidence for masks. shotwell.ca/posts/masks_an…
I'm sure there's a principled reason to use weak evidence for masks but require drug-style RCTs for vitamin D, but I haven't heard it yet
• • •
Missing some Tweet in this thread? You can try to
force a refresh
This is an open label study of 584 Brazillian Covid patients. Study participants took either hydroxychloroquine, nitazoxanide or ivermectin and none (!!) of them went to the hospital or died.
Now there's certainly something wrong with this study. 16% of Brazillian Covid patients go to the hospital so the odds of finding one drug that eliminates hospitalization are small; the odds of finding three in one trial are basically zero.
The reason I'm tweeting about this is that 80% of the patients in the trial were given vitamin D according to clinical abnormalities. I wrote to the author to ask what those were and what dose was given. Could vitamin D confound a study this badly?